Natixis »

Rhythm Pharmaceuticals shares owned by Natixis

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Natixis

Quarter filed Position value Share count Share price at filing
2024-03-31 $262k 6.1k 43.33

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Coinbase Global Com Cl A (COIN)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Select Sector Spdr Tr Indl (XLI)
Energy Transfer Com Ut Ltd Ptn (ET)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Cisco Systems (CSCO)
Meta Platforms Cl A (META)

View all positions for Natixis

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
BlackRock
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Vanguard Group
Perceptive Advisors
NEA Management Company
Federated Investors
Frazier Life Sciences Management
Rock Springs Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Commodore Capital
Checkpoint Capital

View all funds holding Rhythm Pharmaceuticals